electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference

    NEXT STORY
    BIOLIFE4D Appoints Management Advisory Board
    PREV STORY
    Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP

    - TransCon CNP delivered continuous exposure of CNP at target levels for seven days ...

    author_avatar
    NASDAQ Market News

    SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement

    Proceeds used towards advancement of clinical programs NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    SciCann Therapeutics launch liver disease research program in Tel Aviv University

    author_avatar
    NASDAQ Market News